AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: Regulation of the akt downstream pathway

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Shemesh, Itay Israel ^a   Rozen Zvi, Benaya ^b,c   Kalechman, Yona ^a   Gafter, Uzi ^b,c   Sredni, Benjamin ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM TRICHLORO(DIOXYETHYLENE O,O')TELLURATE; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SMAD3 PROTEIN; TRANSCRIPTION FACTOR FKHRL1; AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE; ETHYLENE DERIVATIVE; GLUCOSE BLOOD LEVEL; MADH3 PROTEIN, RAT; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PTEN PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL SIZE; CELL VIABILITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY HYPERTROPHY; LOW DRUG DOSE; MALE; MESANGIUM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEINURIA; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; GENE EXPRESSION; GENETICS; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ETHYLENES; GENE EXPRESSION; MESANGIAL CELLS; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; RATS; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84916229097     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114287     Document Type: Article

References (53)

1. Schena FP, Gesualdo L (2005) Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16 Suppl 1: S30-33.
2. Schellhase KG, Koepsell TD, Weiss NS (2005) Glycemic control and the risk of multiple microvascular diabetic complications. Fam Med 37: 125-130.
3. Mehdi UF, Adams-Huet B, Raskin P, Vega GL, Toto RD (2009) Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. J Am Soc Nephrol 20: 2641-2650.
4. Choudhury D, Tuncel M, Levi M (2010) Diabetic nephropathy - a multifaceted target of new therapies. Discov Med 10: 406-415.
5. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
6. Alsaad KO, Herzenberg AM (2007) Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. J Clin Pathol 60: 18-26.
7. Mason RM, Wahab NA (2003) Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14: 1358-1373.
8. Chen S, Jim B, Ziyadeh FN (2003) Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23: 532-543.
9. Goldfarb S, Ziyadeh FN (2001) TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy. Trans Am Clin Climatol Assoc 112: 27-32; discussion 33.
10. Sharma K, McGowan TA (2000) TGF-beta in diabetic kidney disease: role of novel signaling pathways. Cytokine Growth Factor Rev 11: 115-123.
11. Schiffer M, von Gersdorff G, Bitzer M, Susztak K, Böttinger EP (2000) Smad proteins and transforming growth factor-beta signaling. Kidney Int Suppl 77: S45-52.
12. Runyan CE, Schnaper HW, Poncelet AC (2004) The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 279: 2632-2639.
13. Wu D, Peng F, Zhang B, Ingram AJ, Gao B, et al. (2007) Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells. Diabetologia 50: 2008-2018.
14. Wu D, Peng F, Zhang B, Ingram AJ, Kelly DJ, et al. (2009) EGFR-PLCgamma1 signaling mediates high glucose-induced PKCbeta1-Akt activation and collagen I upregulation in mesangial cells. Am J Physiol Renal Physiol 297: F822-834.
15. García Z, Kumar A, Marqués M, Cortés I, Carrera AC (2006) Phosphoinositide 3-kinase controls early and late events in mammalian cell division. EMBO J 25: 655-661.
16. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274.
17. Kalechman Y, Gafter U, Weinstein T, Chagnac A, Freidkin I, et al. (2004) Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3. J Biol Chem 279: 24724-24732.
18. Kalechman Y, Sredni B, Weinstein T, Freidkin I, Tobar A, et al. (2003) Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101. J Am Soc Nephrol 14: 620-630.
19. Layani-Bazar A, Skornick I, Berrebi A, Pauker MH, Noy E, et al. (2014) Redox Modulation of Adjacent Thiols in VLA-4 by AS101 Converts Myeloid Leukemia Cells from a Drug-Resistant to Drug-Sensitive State. Cancer Res 74: 3092-3103.
20. Wolf G, Ziyadeh FN (1999) Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56: 393-405.
21. Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FC (2008) From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 57: 1439-1445.
22. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN (1992) High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney Int 42: 647-656.
23. Sakaguchi M, Isono M, Isshiki K, Sugimoto T, Koya D, et al. (2006) Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Biochem Biophys Res Commun 340: 296-301.
24. Sheu ML, Ho FM, Chao KF, Kuo ML, Liu SH (2004) Activation of phosphoinositide 3-kinase in response to high glucose leads to regulation of reactive oxygen species-related nuclear factor-kappaB activation and cyclooxygenase-2 expression in mesangial cells. Mol Pharmacol 66: 187-196.
25. Wan-Xin T, Tian-Lei C, Ben W, Wei-Hua W, Ping F (2012) Effect of mitofusin 2 overexpression on the proliferation and apoptosis of high-glucose-induced rat glomerular mesangial cells. J Nephrol 25: 1023-1030.
26. Jeong SI, Kim SJ, Kwon TH, Yu KY, Kim SY (2012) Schizandrin prevents damage of murine mesangial cells via blocking NADPH oxidase-induced ROS signaling in high glucose. Food Chem Toxicol 50: 1045-1053.
27. Datta SR, Dudek H, Tao X, Masters S, Fu H, et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241.
28. Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, et al. (2002) FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol 156: 531-542.
29. Kato M, Yuan H, Xu ZG, Lanting L, Li SL, et al. (2006) Role of the Akt/FoxO3a pathway in TGF-beta1- mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J Am Soc Nephrol 17: 3325-3335.
30. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, et al. (2002) PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8: 1153-1160.
31. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, et al. (2001) Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3: 245-252.
32. Medema RH, Kops GJ, Bos JL, Burgering BM (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782-787.
33. Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511.
34. Wei W, Jin J, Schlisio S, Harper JW, Kaelin WG (2005) The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8: 25-33.
35. Welcker M, Singer J, Loeb KR, Grim J, Bloecher A, et al. (2003) Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol Cell 12: 381-392.
36. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, et al. (2004) A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6: 308-318.
37. Kim MY, Lim JH, Youn HH, Hong YA, Yang KS, et al. (2013) Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1a axis in db/db mice. Diabetologia 56: 204-217.
38. Ho C, Lee PH, Hsu YC, Wang FS, Huang YT, et al. (2012) Sustained Wnt/β-catenin signaling rescues high glucose induction of transforming growth factor-β1-mediated renal fibrosis. Am J Med Sci 344: 374-382.
39. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124: 471-484.
40. Yang Y, Wang J, Qin L, Shou Z, Zhao J, et al. (2007) Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol 27: 495-502.
41. Lloberas N, Cruzado JM, Franquesa M, Herrero-Fresneda I, Torras J, et al. (2006) Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J Am Soc Nephrol 17: 1395-1404.
42. James LR, Le C, Scholey JW (2010) Influence of glucosamine on glomerular mesangial cell turnover: implications for hyperglycemia and hexosamine pathway flux. Am J Physiol Endocrinol Metab 298: E210-221.
43. Nagai K, Matsubara T, Mima A, Sumi E, Kanamori H, et al. (2005) Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int 68: 552-561.
44. Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW, et al. (2004) eIF4E-from translation to transformation. Oncogene 23: 3172-3179.
45. Lu Q, Zhai Y, Cheng Q, Liu Y, Gao X, et al. (2013) The Akt-FoxO3a-manganese superoxide dismutase pathway is involved in the regulation of oxidative stress in diabetic nephropathy. Exp Physiol 98: 934-945.
46. Xu F, Wang Y, Cui W, Yuan H, Sun J, et al. (2014) Resveratrol Prevention of Diabetic Nephropathy Is Associated with the Suppression of Renal Inflammation and Mesangial Cell Proliferation: Possible Roles of Akt/NF-kappaB Pathway. Int J Endocrinol 2014: 289327.
47. Li X, Talts U, Talts JF, Arman E, Ekblom P, et al. (2001) Akt/PKB regulates laminin and collagen IV isotypes of the basement membrane. Proc Natl Acad Sci U S A 98: 14416-14421.
48. Ricupero DA, Poliks CF, Rishikof DC, Cuttle KA, Kuang PP, et al. (2001) Phosphatidylinositol 3- kinase-dependent stabilization of alpha1(I) collagen mRNA in human lung fibroblasts. Am J Physiol Cell Physiol 281: C99-C105.
49. Reif S, Lang A, Lindquist JN, Yata Y, Gabele E, et al. (2003) The role of focal adhesion kinasephosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem 278: 8083-8090.
50. Guo X, Ramirez A, Waddell DS, Li Z, Liu X, et al. (2008) Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling. Genes Dev 22: 106-120.
51. Russo RC, Garcia CC, Barcelos LS, Rachid MA, Guabiraba R, et al. (2011) Phosphoinositide 3- kinase c plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice. J Leukoc Biol 89: 269-282.
52. Son G, Hines IN, Lindquist J, Schrum LW, Rippe RA (2009) Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis. Hepatology 50: 1512-1523.
53. Leehey DJ, Song RH, Alavi N, Singh AK (1995) Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 44: 929-935.